* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 17 cents per share for the quarter ended in March. The mean
expectation of three analysts for the quarter was for a loss
of 15 cents per share.
* Revenue rose 44.6% to $12.49 million from a year ago;
analysts
expected $11.12 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss
of 17 cents.
* The mean earnings estimate of analysts had fallen by
about 2.9%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Apyx Medical Corp shares had fallen by 52.4% this
quarter and
lost 75.7% so far this year.
* The company reported a quarterly loss of $5.95 million.
* Wall Street's median 12-month price target for Apyx
Medical Corp
is $15.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated May 12 at 02:07 p.m. All
figures in US dollars unless otherwise stated